COMPOSITIONS AND METHODS FOR MODULATING GUANYLYL CYCLASE SIGNALING RECEPTOR (GC-C) ACTIVITY AND FOR TREATING MENIERE'S DISEASE

Details for Australian Patent Application No. 2002311556 (hide)

Owner ZEALAND PHARMA A/S

Inventors QVORTRUP, Klaus; PETERSEN, Jorgen, Soberg; MEIER, Eddi; LARSEN, Bjarne, Due; NEVE, Soren

Pub. Number AU-A-2002311556

PCT Number PCT/IB02/02466

PCT Pub. Number WO2002/079235

Priority PA 2001 00534 30.03.01 DK

Filing date 29 March 2002

Wipo publication date 15 October 2002

International Classifications

C07K 007/00 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): PA 2001 00534 30.03.01 DK

3 April 2003 Application Open to Public Inspection

  Published as AU-A-2002311556

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002311557-CONDITIONAL ACCESS SYSTEM

2002311555-RECEIVER APPARATUS AND METHOD